Korea and Australia’s P&MA Shift: From Local Launch Opportunities to Regional Blueprint.
The article focuses on recent policy shifts in Korea and Australia that are transforming their pharmaceutical pricing and market access (P&MA) landscapes, making them more favorable for innovative therapies. Both countries are implementing reforms aimed at expediting access to new drugs, with Korea...
| Publicado en: | Pharmaceutical Executive Vol. 45; no. 9; pp. 11 - 14 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Dec2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |